Note to new investorsSernova has explicitly stated they have collaborations with Big Pharma in their annual reports (check SEDAR). These pre-clinicals have been ongoing for quite some time and names can't be mentioned due to NDAs. Any day we could have a news release detailing the results of collaboration and with mere mention of any big pharma name, these prices are history.
Buyout offers aside, collaboration deals will be soon flooding in as big pharma try to use their cells in the Cell Pouch which has now been proven to be SAFE and EFFECTIVE. Cells are abundant but we have the only device all the different cells need to be implanted into the body.
I don't really give a rats a$$ what you do but you will regret selling shares too early. 1.84 to the conservative analyst target of 2.50 is a 35% gain. This doesn't take into considerations any collaborations or licensing deals. GLTA